Sandu Pharmaceuticals Ltd

NSE: BSE: 524703

₹35

(-1.07%)

Tue, 10 Mar 2026, 06:54 pm

MTF 5xInvest in Sandu Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap338.13M

PE Ratio16.50

Dividend2.29

Health Technology

Pharmaceuticals: Other

24.5K

Sandu Pharmaceuticals Price to Cash Flow Ratio

D/E EV EV/EBITDA P/B P/CF P/E P/S ROE %

Particulars	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Price to earnings ratio	6.31	13.68	10.79	21.54	10.91	14.17	37.93	32.43	52.92	36.27	23.07	11.55	20.73	37.64	32.38	37.94	30.50
Price to book ratio	0.37	0.61	0.54	0.61	0.49	0.39	0.86	0.93	0.82	0.72	0.54	0.28	0.76	1.70	1.29	1.37	1.13
Price to sales ratio	0.38	0.61	0.41	0.38	0.29	0.20	0.41	0.45	0.52	0.41	0.31	0.17	0.39	0.91	0.75	0.82	0.70
Price to cash flow ratio	48.12	8.83	9.49	0	2.45	0	4.45	0	6.54	728.44	5.64	1.44	2.95	64.95	164.40	64.76	49.53
Enterprise value	81.26M	111.01M	100.77M	134.94M	133.57M	155.02M	238.69M	281.49M	303.48M	282.97M	208.17M	80.24M	110.1M	556.47M	469.43M	543.01M	451.54M
Enterprise value to EBITDA ratio	5.09	7.12	6.03	7.30	6.88	7.24	10.59	9.80	16.27	11.42	9.78	5.50	5.12	19.35	18.88	23.65	16.33
Debt to equity ratio	0.19	0.19	0.17	0.24	0.48	0.55	0.69	0.61	0.39	0.34	0.21	0.04	0	0	0	0	0.01
Return on equity %	0	4.55	5.13	2.92	4.53	2.78	2.28	2.92	-1.93	2.38	2.35	2.48	3.48	4.54	4.02	3.66	3.76

Sandu Pharmaceuticals Ltd Price to Cash Flow Ratio

The Sandu Pharmaceuticals Ltd Price to Cash Flow Ratio is a key financial metric used by investors to evaluate Sandu Pharmaceuticals Ltd's valuation, profitability, and overall financial performance. Tracking the Sandu Pharmaceuticals Ltd Price to Cash Flow Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Sandu Pharmaceuticals Ltd (NSE: , BSE: 524703) is currently trading at ₹35, with a market capitalization of ₹338.13M. As a leading company in the Health technology sector and Pharmaceuticals: other industry, monitoring the Sandu Pharmaceuticals Ltd Price to Cash Flow Ratio is essential for fundamental analysis.

Sandu Pharmaceuticals Ltd Price to Cash Flow Ratio Current Value

The current Sandu Pharmaceuticals Ltd Price to Cash Flow Ratio stands at 49.53.

The Sandu Pharmaceuticals Ltd Price to Cash Flow Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Sandu Pharmaceuticals Ltd Price to Cash Flow Ratio Historical Trend

The Sandu Pharmaceuticals Ltd Price to Cash Flow Ratio has shown the following historical trend:

2024: 49.53
2023: 64.76
2022: 164.40
2021: 64.95
2020: 2.95

The decline in Sandu Pharmaceuticals Ltd Price to Cash Flow Ratio indicates improving financial efficiency or better earnings growth.

What Sandu Pharmaceuticals Ltd Price to Cash Flow Ratio Indicates for Investors

The Sandu Pharmaceuticals Ltd Price to Cash Flow Ratio plays a crucial role in understanding the company's financial health and valuation.

The P/CF ratio indicates how much investors pay for company cash flow.

Sandu Pharmaceuticals Ltd Price to Cash Flow Ratio Analysis Summary

The Sandu Pharmaceuticals Ltd Price to Cash Flow Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Sandu Pharmaceuticals Ltd Price to Cash Flow Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Sandu Pharmaceuticals Ltd Price to Cash Flow Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800